Abstract
There is robust epidemiological evidence that susceptibility to tuberculosis is in part heritable. This has driven the use of genetics to try to find the genes and pathways involved that could in the longer term contribute towards the development of new therapies and a better vaccine for this major global health problem. This paper reviews the progress made in the field to date, and discusses the challenges inherent in undertaking genetics studies on a complex disease with clinically diverse phenotypes, that affects many genetically different populations and which is further complicated by the presence of a pathogen which has a genome too.
Keywords: Genetic linkage, genome wide association studies, immune response genes, Mendelian susceptibility to mycobacterial disease, single nucleotide polymorphisms, tuberculosis.
Current Respiratory Medicine Reviews
Title:The Contribution of Host Genetics to TB Disease
Volume: 9 Issue: 3
Author(s): Melanie J. Newport
Affiliation:
Keywords: Genetic linkage, genome wide association studies, immune response genes, Mendelian susceptibility to mycobacterial disease, single nucleotide polymorphisms, tuberculosis.
Abstract: There is robust epidemiological evidence that susceptibility to tuberculosis is in part heritable. This has driven the use of genetics to try to find the genes and pathways involved that could in the longer term contribute towards the development of new therapies and a better vaccine for this major global health problem. This paper reviews the progress made in the field to date, and discusses the challenges inherent in undertaking genetics studies on a complex disease with clinically diverse phenotypes, that affects many genetically different populations and which is further complicated by the presence of a pathogen which has a genome too.
Export Options
About this article
Cite this article as:
Newport J. Melanie, The Contribution of Host Genetics to TB Disease, Current Respiratory Medicine Reviews 2013; 9 (3) . https://dx.doi.org/10.2174/1573398X113099990022
DOI https://dx.doi.org/10.2174/1573398X113099990022 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Molecular Approach to Targeted Therapy for Multiple Sclerosis
CNS & Neurological Disorders - Drug Targets Targeting Bacterial Metalloenzymes: A New Strategy for the Development of Anti-Infective Agents
Anti-Infective Agents in Medicinal Chemistry γ δ T Cells and Dendritic Cells: Close Partners and Biological Adjuvants for New Therapies
Current Molecular Medicine Bacterial Cell Division Regulation by Ser/Thr Kinases: A Structural Perspective
Current Protein & Peptide Science New Insights into Ocular Complications of Human Immunodeficiency Virus Infection
Current HIV Research Safety and Efficacy of Thioridazine as Salvage Therapy in Indian Patients with XDR-TB
Recent Patents on Anti-Infective Drug Discovery A Comprehensive Review on DNA Gyrase Inhibitors
Infectious Disorders - Drug Targets Insights in Nanoparticle-Bacterium Interactions: New Frontiers to Bypass Bacterial Resistance to Antibiotics
Current Pharmaceutical Design Bacterial RNA Polymerase Inhibitors: An Organized Overview of their Structure, Derivatives, Biological Activity and Current Clinical Development Status
Current Medicinal Chemistry Identification and Characterization of a Novel Oligomeric Decaprenyl Diphosphate Synthase
Protein & Peptide Letters Drug Delivery Nanosystems in Glioblastoma Multiforme Treatment: Current State of the Art
Current Neuropharmacology Treatment of Opportunistic Infections Prior to HAART Initiation Does Not Affect Immune Reconstitution in HIV-Infected Patients
Current HIV Research Subject Index To Volume 6
Infectious Disorders - Drug Targets Anti-Tuberculosis
Current Bioactive Compounds Evasion of Host Immunity by Virulent Salmonella: Implications for Vaccine Design
Current Medicinal Chemistry Increased [11C]Choline Uptake in Bronchioloalveolar Cell Carcinoma with Negative [18F]FDG Uptake. A PET/CT and Pathology Study
Current Radiopharmaceuticals Biotechnology in the Development of New Vaccines and Diagnostic Reagents Against Tuberculosis
Current Pharmaceutical Biotechnology Tuberculosis, an Old Disease Lacking New Therapeutic Drugs
Current Drug Therapy COVID-19: Are Experimental Drugs a Cure or Cause?
Current Drug Safety Real-time Polymerase Chain Reaction for Mycobacterium tuberculosis Meningitis is More Sensitive in Patients with HIV Co-Infection
Current HIV Research